Tamoxifen effects on endothelial function and cardiovascular risk factors in men with advanced atherosclerosis

Circulation

Volumn 103, Issue 11, 2001, Pages 1497-1502

  Clarke, Sarah C ^a,b   Schofield, Peter M ^a,b   Grace, Andrew A ^a,b   Metcalfe, James C ^a,b   Kirschenlohr, Heide L ^a,b  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Atherosclerosis; Endothelium; Hormones; Lipids; Vasodilation

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOPROTEIN; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; TAMOXIFEN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENDOTHELIUM; HEART FUNCTION; HUMAN; MALE; PRIORITY JOURNAL; RISK FACTOR; ULTRASOUND;

EID: 0035916902     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.11.1497     Document Type: Article

References (25)

1. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial: The Scottish Breast Cancer Committee
2. Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomised trial: The Scottish Cancer Trials Breast Group
3. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen: The Stockholm Breast Cancer Study Group
4. The effect of the antiestrogen tamoxifen on bone mineral density in normal late postmenopausal women
5. Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial
6. The potential of SERMs for reducing the risk of coronary heart disease
7. Preventing postmenopausal osteoporosis: An update on raloxifene
8. Arterial reactivity is enhanced in genetic males taking high dose estrogens
9. Long-term estrogen therapy improves vascular function in male to female transsexuals
10. Carcinoma of the male breast
11. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen
12. Salvage chemotherapy with tamoxifen for recurrent anaplastic astrocytomas
13. Estrogens, progestins, and heart disease: Can endothelial function divine the benefit?
14. Large coronary arteries in humans are responsive to changing blood flow: An endothelium-dependent mechanism that fails in patients with atherosclerosis
15. Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease
16. The correlation between coronary stenosis index and flow-mediated dilation of the brachial artery
17. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
18. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility
19. Non-invasive measurement of endothelial function: Effect on brachial artery dilatation of graded endothelial dependent and independent stimuli
20. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women
21. Measuring plasma fibrinogen to predict stroke and myocardial infarction: An update
22. Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women
23. Antiatherogenic effects of adjuvant antiestrogens: A randomized trial comparing the effects of tamoxifen and toremifene on plasma lipid levels in postmenopausal women with node-positive breast cancer
24. Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication
25. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)